Market Cap 747.81M
Revenue (ttm) 106.47M
Net Income (ttm) 83.23M
EPS (ttm) N/A
PE Ratio 10.21
Forward PE 23.16
Profit Margin 78.17%
Debt to Equity Ratio 0.00
Volume 1,259,000
Avg Vol 1,571,198
Day's Range N/A - N/A
Shares Out 59.12M
Stochastic %K 59%
Beta 0.91
Analysts Strong Sell
Price Target $28.25

Company Profile

Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States. The company develops its products through Ligand Activated Technology platform. Its lead product candidate is KP1077, consisting of KP1077IH, which is under Phase 3 clinical trial for the treatment of idiopathic hypersomnia, and KP1077N, which is under Phase 3 clinical trial to treat narcolepsy. The company is developing Celiprolol, an investigational p...

Industry: Biotechnology
Sector: Healthcare
Phone: 888 958 1253
Address:
101 Federal Street, Suite 103, Boston, United States
KemPharm_rocks
KemPharm_rocks Jun. 17 at 1:00 AM
$ZVRA Okay, so let’s see if I can play Nostradamus for a moment here, and make some predictions based on what we saw today. Let’s break down the types of shorts who might start panicking before this Friday’s expiration, and what that could look like. First the ones who are most likely to crack early retail and small, speculative shorts. Seeing the stock hold above $12 and the $12 calls gaining value makes their losses real and immediate. They have the least staying power. Next, the leveraged hedge funds and short-term traders, the funds that use leverage or have tight risk limits, who begin feeling a significant level of pressure. If their stop-loss levels or risk models are triggered, they may cover to avoid larger drawdowns. Finally, the market makers hedging options, who often end up short stock, while hedging the calls they sold. As those calls move deeper in-the-money, they may need to buy back shares to rebalance, adding fuel to any upward move. Right or wrong, time will tell 😉.
0 · Reply
Jhh3796
Jhh3796 Jun. 16 at 8:50 PM
$ZVRA Well that escalated quickly.
1 · Reply
ZVRA100
ZVRA100 Jun. 16 at 5:41 PM
$ZVRA 🥱
0 · Reply
ekoostik16
ekoostik16 Jun. 16 at 5:02 PM
$ZVRA It would be awesome if this is the last handle before breakout on the 1y & 5y charts. Interesting how both charts look very similar.
0 · Reply
Wwnate23
Wwnate23 Jun. 16 at 4:57 PM
$RFL holding strong $ZVRA
0 · Reply
KemPharm_rocks
KemPharm_rocks Jun. 16 at 4:35 PM
$ZVRA accumulators seem to be taking advantage of the games, as they should. Seems like a great week to load up!
0 · Reply
Marketman707
Marketman707 Jun. 16 at 4:27 PM
$ZVRA interesting we are going up on such low volume…
0 · Reply
XL10
XL10 Jun. 16 at 4:25 PM
$ZVRA Strong intraday candle!
0 · Reply
EthanStawk
EthanStawk Jun. 16 at 3:27 PM
$ZVRA Really happy for this opportunity to load back up... I am now loaded, let's rock and roll.
0 · Reply
KemPharm_rocks
KemPharm_rocks Jun. 16 at 3:15 PM
$ZVRA well, that dip was weird 🥸
0 · Reply
Latest News on ZVRA
Zevra Therapeutics chief medical officer to step down

2026-06-11T13:15:49.000Z - 5 days ago

Zevra Therapeutics chief medical officer to step down


Zevra Therapeutics Slides: Corporate presentation

Jun 2, 2026, 7:00 AM EDT - 14 days ago

Zevra Therapeutics Slides: Corporate presentation


Zevra Therapeutics reports Q1 EPS 60c, consensus 8c

2026-05-07T00:44:27.000Z - 5 weeks ago

Zevra Therapeutics reports Q1 EPS 60c, consensus 8c


Zevra Therapeutics Earnings Call Transcript: Q1 2026

May 6, 2026, 4:30 PM EDT - 5 weeks ago

Zevra Therapeutics Earnings Call Transcript: Q1 2026


Zevra Therapeutics Earnings release: Q1 2026

May 6, 2026, 4:30 PM EDT - 5 weeks ago

Zevra Therapeutics Earnings release: Q1 2026


Zevra Therapeutics Quarterly report: Q1 2026

May 6, 2026, 4:30 PM EDT - 5 weeks ago

Zevra Therapeutics Quarterly report: Q1 2026


Zevra Therapeutics Proxy statement: Proxy filing

Apr 20, 2026, 8:00 AM EDT - 2 months ago

Zevra Therapeutics Proxy statement: Proxy filing


Zevra Therapeutics Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 2 months ago

Zevra Therapeutics Proxy statement: Proxy filing


Zevra Therapeutics Slides: Corporate presentation

Apr 6, 2026, 7:00 AM EDT - 2 months ago

Zevra Therapeutics Slides: Corporate presentation


Zevra Therapeutics sells SDX portfolio to Commave for $50M

2026-03-16T11:35:43.000Z - 3 months ago

Zevra Therapeutics sells SDX portfolio to Commave for $50M


Zevra Therapeutics initiated with a Buy at BTIG

2026-03-16T10:41:37.000Z - 3 months ago

Zevra Therapeutics initiated with a Buy at BTIG


Zevra Therapeutics Earnings Call Transcript: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 3 months ago

Zevra Therapeutics Earnings Call Transcript: Q4 2025


Zevra Therapeutics Annual report: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 3 months ago

Zevra Therapeutics Annual report: Q4 2025


Zevra Therapeutics Earnings release: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 3 months ago

Zevra Therapeutics Earnings release: Q4 2025


Zevra Therapeutics reports Q4 EPS 20c, consensus 5c

2026-03-09T20:20:20.000Z - 3 months ago

Zevra Therapeutics reports Q4 EPS 20c, consensus 5c


Zevra Therapeutics Slides: Corporate presentation

Mar 9, 2026, 7:00 AM EDT - 3 months ago

Zevra Therapeutics Slides: Corporate presentation


Zevra Therapeutics appoints Renz as Chief Financial Officer

2026-03-05T13:09:46.000Z - 3 months ago

Zevra Therapeutics appoints Renz as Chief Financial Officer

ARDX


Zevra Therapeutics presents real-world data on Miplyffa

2026-02-04T12:36:22.000Z - 4 months ago

Zevra Therapeutics presents real-world data on Miplyffa


Zevra Therapeutics, Inc. Announces CFO Transition

Nov 20, 2025, 4:05 PM EST - 7 months ago

Zevra Therapeutics, Inc. Announces CFO Transition


Zevra Therapeutics Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:30 PM EST - 7 months ago

Zevra Therapeutics Earnings Call Transcript: Q3 2025


Zevra Therapeutics Quarterly report: Q3 2025

Nov 5, 2025, 4:30 PM EST - 7 months ago

Zevra Therapeutics Quarterly report: Q3 2025


Zevra Therapeutics Earnings release: Q3 2025

Nov 5, 2025, 4:30 PM EST - 7 months ago

Zevra Therapeutics Earnings release: Q3 2025


Zevra Therapeutics Slides: Corporate Presentation

Nov 4, 2025, 6:00 PM EST - 8 months ago

Zevra Therapeutics Slides: Corporate Presentation


Zevra Therapeutics Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Zevra Therapeutics Earnings Call Transcript: Q2 2025


Zevra Therapeutics Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Zevra Therapeutics Quarterly report: Q2 2025


Zevra Therapeutics Earnings release: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Zevra Therapeutics Earnings release: Q2 2025


Zevra Therapeutics Slides: Corporate Presentation

Aug 12, 2025, 4:00 PM EDT - 11 months ago

Zevra Therapeutics Slides: Corporate Presentation


Zevra Therapeutics Slides: Corporate Presentation

Jun 2, 2025, 7:00 AM EDT - 1 year ago

Zevra Therapeutics Slides: Corporate Presentation


Zevra Therapeutics Proxy statement: Proxy Filing

May 21, 2025, 8:00 AM EDT - 1 year ago

Zevra Therapeutics Proxy statement: Proxy Filing


Zevra Therapeutics Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Zevra Therapeutics Earnings Call Transcript: Q1 2025


Zevra Therapeutics Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Zevra Therapeutics Quarterly report: Q1 2025


Zevra Therapeutics Earnings release: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Zevra Therapeutics Earnings release: Q1 2025


Zevra Therapeutics Proxy statement: Proxy Filing

May 8, 2025, 8:00 AM EDT - 1 year ago

Zevra Therapeutics Proxy statement: Proxy Filing


Zevra Therapeutics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Zevra Therapeutics Proxy statement: Proxy Filing


Zevra Therapeutics Proxy statement: Proxy Filing

Apr 21, 2025, 8:00 AM EDT - 1 year ago

Zevra Therapeutics Proxy statement: Proxy Filing


Zevra Therapeutics Proxy statement: Proxy Filing

Apr 21, 2025, 8:00 AM EDT - 1 year ago

Zevra Therapeutics Proxy statement: Proxy Filing


Zevra Therapeutics Proxy statement: Proxy Filing

Apr 21, 2025, 8:00 AM EDT - 1 year ago

Zevra Therapeutics Proxy statement: Proxy Filing


Zevra Therapeutics Proxy statement: Proxy Filing

Apr 10, 2025, 8:00 AM EDT - 1 year ago

Zevra Therapeutics Proxy statement: Proxy Filing


Zevra Therapeutics Proxy statement: Proxy Filing

Apr 7, 2025, 8:00 AM EDT - 1 year ago

Zevra Therapeutics Proxy statement: Proxy Filing


Zevra Therapeutics Files Preliminary Proxy

Mar 31, 2025, 4:12 PM EDT - 1 year ago

Zevra Therapeutics Files Preliminary Proxy


Zevra Therapeutics Proxy statement: Proxy Filing

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Zevra Therapeutics Proxy statement: Proxy Filing


Zevra Therapeutics Proxy statement: Proxy Filing

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Zevra Therapeutics Proxy statement: Proxy Filing


Zevra Therapeutics Proxy statement: Proxy Filing

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Zevra Therapeutics Proxy statement: Proxy Filing


Zevra Therapeutics Earnings Call Transcript: Q4 2024

Mar 11, 2025, 4:30 PM EDT - 1 year ago

Zevra Therapeutics Earnings Call Transcript: Q4 2024


Zevra Therapeutics Annual report: Q4 2024

Mar 11, 2025, 4:30 PM EDT - 1 year ago

Zevra Therapeutics Annual report: Q4 2024


Zevra Therapeutics Earnings release: Q4 2024

Mar 11, 2025, 4:30 PM EDT - 1 year ago

Zevra Therapeutics Earnings release: Q4 2024


Zevra to Participate at Upcoming Investor Conferences

Feb 24, 2025, 4:02 PM EST - 1 year ago

Zevra to Participate at Upcoming Investor Conferences


Zevra Therapeutics Announces Organizational Changes

Dec 6, 2024, 5:00 PM EST - 1 year ago

Zevra Therapeutics Announces Organizational Changes


Zevra Therapeutics Earnings Call Transcript: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Zevra Therapeutics Earnings Call Transcript: Q3 2024


Zevra Therapeutics Quarterly report: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Zevra Therapeutics Quarterly report: Q3 2024


Zevra Therapeutics Earnings release: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Zevra Therapeutics Earnings release: Q3 2024


Zevra Therapeutics Slides: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Zevra Therapeutics Slides: Q3 2024


KemPharm_rocks
KemPharm_rocks Jun. 17 at 1:00 AM
$ZVRA Okay, so let’s see if I can play Nostradamus for a moment here, and make some predictions based on what we saw today. Let’s break down the types of shorts who might start panicking before this Friday’s expiration, and what that could look like. First the ones who are most likely to crack early retail and small, speculative shorts. Seeing the stock hold above $12 and the $12 calls gaining value makes their losses real and immediate. They have the least staying power. Next, the leveraged hedge funds and short-term traders, the funds that use leverage or have tight risk limits, who begin feeling a significant level of pressure. If their stop-loss levels or risk models are triggered, they may cover to avoid larger drawdowns. Finally, the market makers hedging options, who often end up short stock, while hedging the calls they sold. As those calls move deeper in-the-money, they may need to buy back shares to rebalance, adding fuel to any upward move. Right or wrong, time will tell 😉.
0 · Reply
Jhh3796
Jhh3796 Jun. 16 at 8:50 PM
$ZVRA Well that escalated quickly.
1 · Reply
ZVRA100
ZVRA100 Jun. 16 at 5:41 PM
$ZVRA 🥱
0 · Reply
ekoostik16
ekoostik16 Jun. 16 at 5:02 PM
$ZVRA It would be awesome if this is the last handle before breakout on the 1y & 5y charts. Interesting how both charts look very similar.
0 · Reply
Wwnate23
Wwnate23 Jun. 16 at 4:57 PM
$RFL holding strong $ZVRA
0 · Reply
KemPharm_rocks
KemPharm_rocks Jun. 16 at 4:35 PM
$ZVRA accumulators seem to be taking advantage of the games, as they should. Seems like a great week to load up!
0 · Reply
Marketman707
Marketman707 Jun. 16 at 4:27 PM
$ZVRA interesting we are going up on such low volume…
0 · Reply
XL10
XL10 Jun. 16 at 4:25 PM
$ZVRA Strong intraday candle!
0 · Reply
EthanStawk
EthanStawk Jun. 16 at 3:27 PM
$ZVRA Really happy for this opportunity to load back up... I am now loaded, let's rock and roll.
0 · Reply
KemPharm_rocks
KemPharm_rocks Jun. 16 at 3:15 PM
$ZVRA well, that dip was weird 🥸
0 · Reply
CyberspaceCowboy
CyberspaceCowboy Jun. 16 at 3:02 PM
$ZVRA one of the only undervalued stonks in this market
0 · Reply
KemPharm_rocks
KemPharm_rocks Jun. 16 at 2:31 PM
$ZVRA So don’t say @jemer didn’t warn you. You are now facing a Triple Witching Friday, Max Pain, and institutional Gamma Unwinding. Welcome to your friend pal, Wall Street! Go long, or don’t bother being here. Full disclosure, I am not a financial advisor and this is not financial advice 🤣.
0 · Reply
Marketman707
Marketman707 Jun. 16 at 2:04 PM
$ZVRA 12.40 buy order went through! Now just waiting on 12.20!
2 · Reply
rickdplumr
rickdplumr Jun. 16 at 1:57 PM
$ZVRA I am hoping to add more when the price is right...so I wait...GL all 😉
0 · Reply
ZacksResearch
ZacksResearch Jun. 16 at 1:43 PM
$ZVRA just strengthened MIPLYFFA’s moat — and the market is paying attention 🔒 📌 Zevra submitted U.S. Patent No. 11,707,456 for MIPLYFFA to the FDA’s Orange Book, with patent protection extending to November 19, 2041. 📌 The listing reinforces exclusivity around a treatment for Niemann-Pick disease type C, while a separate patent term extension application remains pending. Latest ZVRA news here 👉 https://www.zacks.com/stock/quote/ZVRA?cid=sm-stocktwits-0-quote_overview-oc-38428&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_38428
0 · Reply
Alvarados10
Alvarados10 Jun. 16 at 1:42 PM
$ZVRA I want $12.50
1 · Reply
lance1965
lance1965 Jun. 16 at 1:39 PM
$ZVRA Maybe we can get back into the $13.00's today!
1 · Reply
BMW2002
BMW2002 Jun. 16 at 1:09 PM
0 · Reply
111ggg
111ggg Jun. 15 at 9:02 PM
$ZVRA guess I was wrong. I thought we would gain a few pennies today.
0 · Reply
KemPharm_rocks
KemPharm_rocks Jun. 15 at 7:56 PM
$ZVRA So is @jemer correct? Is this what this week’s pps is all about… getting it to $12.00 by this Friday, so nobody’s call-options print?
0 · Reply
XL10
XL10 Jun. 15 at 7:30 PM
$ZVRA Come on, just a little more, and the gap will be closed.
0 · Reply
EthanStawk
EthanStawk Jun. 15 at 7:10 PM
$ZVRA ...and there's my exact number for the gap fill.
1 · Reply